The Science Behind Oral GLP-1 Therapies
Oral GLP-1 receptor agonists (like semaglutide tablets) work in the same way as injectable GLP-1 drugs, but with some differences…
Tag: GLP-1
Ozempic May Put Young Women and Their Pregnancies at Risk
Weight-loss drugs like Ozempic and Wegovy are changing the way millions approach health and body weight. But new research warns…
WHO Adds GLP-1 Drugs to Essential Medicines List: What It Means for Global Diabetes Care
In a move that could reshape global diabetes treatment, the World Health Organization (WHO) has officially added GLP-1 receptor agonists—the…
The Next Ozempic? Tufts’ 4-in-1 Weight Loss Drug Could Redefine Obesity Treatment
Weight loss science is entering a new era. For years, drugs like Ozempic and Wegovy have transformed how doctors treat…
Diabesity: The Rising Challenge of Diabetes and Obesity and How Biocon is Taking the Lead
In the world of modern healthcare, there’s a new term that’s creating waves: Diabesity. Coined to capture the dual epidemic…
Retatrutide: The Next-Gen ‘Triple G’ Weight Loss Drug Shows Promising Results
Retatrutide is a promising experimental weight loss drug under development by Eli Lilly. Known as the “Triple G” drug, it…
What is GLORY-1?
GLORY-1 is an innovative investigational therapy in the field of metabolic health, designed as a dual receptor agonist targeting both…